课题基金 / 基金详情

RNA Toxicity and Muscle Regeneration

RNA Toxicity and Muscle Regeneration
RNA 毒性和肌肉再生
批准号:
9252112
负责人:
Mani Subramaniam Mahadevan
金额:
$39.28万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-02-20 至 2021-12-31

项目摘要

项目成果

Mani Subramaniam Mahadevan的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary: Myotonic dystrophy (DM1) is the most common form of muscular dystrophy in adults and children. Though there are a variety of other multi-systemic effects, DM1 is mainly characterized by myotonia and progressive muscle wasting. Muscle weakness, wasting, and fatigue have also been reported as the most impactful adverse outcomes by patients. RNA splicing defects have been identified as key effects of the toxic RNA produced in DM1 patients, and using myoblast cells from mice and DM1 patients, we and others have previously demonstrated the deleterious effects of the toxic RNA on myogenic differentiation. But little is known about the regenerative process in DM1 or the effects of RNA toxicity on this. Addressing this key issue is hampered without a model in which we can develop a thorough understanding of the effects of RNA toxicity on muscle regeneration and one in which to test therapies targeting this process. Satellite cells are key cellular mediators of muscle regeneration in response to damage. Here, we have developed the first RNA toxicity mouse model with demonstrated expression of the toxic RNA in satellite cells. We will use this model to characterize the effects of RNA toxicity on satellite cells and muscle regeneration. We will also study the expression of various key proteins implicated in DM1 such as MBNL1 and CUGBP1 in satellite cells, especially in response to damage. We will also use this model to study the effects of therapeutics on satellite cell function in RNA toxicity. Our goal is to understand the role of RNA toxicity in the process of muscle regeneration in order to provide a platform for developing therapies to treat muscular dystrophy in DM1. .
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The role of TGFβs and cFAPs in Cardiac Pathology from RNA Toxicity
  • 批准号:
    10717904
  • 项目类别:
  • 资助金额:
    $80.7万
  • 财政年份:
    2023
  • 负责人:
    Mani Subramaniam Mahadevan
  • 依托单位:
RNA Toxicity and Cardiac Pathology
  • 批准号:
    10705364
  • 项目类别:
  • 资助金额:
    $75.5万
  • 财政年份:
    2022
  • 负责人:
    Mani Subramaniam Mahadevan
  • 依托单位:
Role of FN14 in RNA Toxicity
  • 批准号:
    8331374
  • 项目类别:
  • 资助金额:
    $34.65万
  • 财政年份:
    2011
  • 负责人:
    Mani Subramaniam Mahadevan
  • 依托单位:
Role of FN14 in RNA Toxicity
  • 批准号:
    8517588
  • 项目类别:
  • 资助金额:
    $32.92万
  • 财政年份:
    2011
  • 负责人:
    Mani Subramaniam Mahadevan
  • 依托单位:
海外基金